Basic research studies to understand aneurysm disease

被引:43
作者
Boddy, Amy M. [1 ]
Lenk, Guy M.
Lillvis, John H. [1 ]
Nischan, Jennifer [1 ]
Kyo, Yoshiki [2 ]
Kuivaniemi, Helena [1 ]
机构
[1] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA
[2] Higashihirosima Med Ctr, Dept Cardiovasc Surg, Hiroshima, Japan
关键词
D O I
10.1358/dnp.2008.21.3.1203410
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Abdominal aortic aneurysm (AAA) is a complex multifactorial disease with life-threatening implications. Aneurysms typically have no signs or symptoms, and rupture of AAA has a high mortality rate. Multiple environmental and genetic risk factors are involved in aneurysm formation and progression making it a complicated disease to study. Little is understood about the mechanisms in disease initiation, thus there are currently no therapeutic approaches to prevent AAA, leaving patients with surgery as their only option. Ongoing research into the genetic components of AAA using a candidate gene approach has been overall unsuccessful. A more promising approach to study complex diseases involves genome-wide techniques such as DNA linkage analysis, genetic association studies and microarray expression profiling. Furthermore, studies involving inhibition of AAA progression, rather than formation, have a potentially promising outcome. Targeting biological pathways in AAA pathogenesis may benefit patients by slowing the growth and possibly preventing the rupture of AAA. Critical pathways involved in AAA pathogenesis include immunological processes, such as T-cell and natural killer cell pathways, oxidative stress, depletion of vascular smooth muscle cells through the process of apoptosis and the destruction of the extracellular matrix by matrix metalloproteinases. (C) 2008 Prous Science, S.A.U. or its licensors. All rights reserved.
引用
收藏
页码:142 / 148
页数:7
相关论文
共 67 条
[31]  
Leuner K, 2007, J NEURAL TRANSM-SUPP, P207
[32]  
LILLVIS JH, IN PRESS GENETICS AB
[33]  
LINDEMAN JH, 2007, CLIN SCI LOND 1213
[34]   Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms [J].
Longo, GM ;
Xiong, WF ;
Greiner, TC ;
Zhao, Y ;
Fiotti, N ;
Baxter, BT .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (05) :625-632
[35]  
Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719
[36]   17β-estradiol attenuates development of angiotensin II induced aortic abdominal aneurysm in apolipoprotein E deficient mice [J].
Martin-McNulty, B ;
Tham, DM ;
da Cunha, V ;
Ho, JJ ;
Wilson, DW ;
Rutledge, JC ;
Deng, GG ;
Vergona, R ;
Sullivan, ME ;
Wang, YX .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (09) :1627-1632
[37]  
Marumo T, 1997, CIRCULATION, V96, P2361
[38]   Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms [J].
McCormick, Michael L. ;
Gavrila, Dan ;
Weintraub, Neal L. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (03) :461-469
[39]   The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: A protein array study [J].
Middleton, Rachel K. ;
Lloyd, Geraint M. ;
Bown, Matthew J. ;
Cooper, Nicola J. ;
London, Nicholas J. ;
Sayers, Robert D. .
JOURNAL OF VASCULAR SURGERY, 2007, 45 (03) :574-580
[40]   Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase [J].
Miralles, M ;
Wester, W ;
Sicard, GA ;
Thompson, R ;
Reilly, JM .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (05) :884-892